Canadian cannabis legalization reduced arrests from 200+ to 50 per 100,000 and kept youth use stable, but increased adult ER visits by 22% and pediatric edible hospitalizations by 7.5-fold.
Policymakers, public health officials, cannabis consumers interested in legalization outcomes, parents, and anyone following the legalization debate.
200 → 50 per 100,000: cannabis offences after legalization. Youth use: stable. Adult ER visits: +22%. Pediatric edible hospitalizations: 7.5x
The Backstory
On October 17, 2018, Canada became the second country in the world — after Uruguay — to legalize recreational cannabis nationally. Not a state-by-state patchwork like the United States. Not decriminalization. Full federal legalization, creating a regulated market for 38 million people overnight.
Every country watching cannabis reform was watching Canada. Proponents predicted the end of the black market, massive tax revenue, and stable public health outcomes. Opponents predicted a surge in youth use, a wave of impaired driving fatalities, and a mental health crisis. Five years later, Wayne Hall — one of the world's most cited cannabis epidemiologists — published a systematic review of what actually happened.
The answer was more complicated than either side expected.
The Researcher
Wayne Hall has been studying cannabis policy for longer than most countries have been debating legalization. An Emeritus Professor at the University of Queensland's National Centre for Youth Substance Use Research, Hall has served as the World Health Organization's expert adviser on cannabis since 1993 — the year he was invited to update a WHO report on cannabis health effects and never stopped.
He has published over 250 papers on substance use policy. In 2014, his comprehensive 20-year review of cannabis adverse effects became a standard reference — the paper that established driving under cannabis influence roughly doubles crash risk, and that regular adolescent use is associated with cognitive and psychiatric harm.
Hall occupies a rare position in the cannabis debate: respected by both public health officials and reform advocates for his even-handed approach. He doesn't campaign for or against legalization. He counts what happens afterward.
What Canada Was Trying to Do
The Cannabis Act (Bill C-45) had specific policy goals. Understanding what Hall's review found requires knowing what the benchmarks were.
Process
Canada's Cannabis Act: Stated Policy Goals
Protect youth
Prevent young people from accessing cannabis by restricting sales to adults (18+, with provinces setting higher ages). Marketing restrictions. Severe penalties for selling to minors.
Eliminate the black market
Create a legal supply chain that would eventually displace illegal cannabis through competitive pricing, quality assurance, and convenience.
Reduce cannabis-related criminal justice burden
End tens of thousands of annual cannabis arrests that disproportionately affected Indigenous and Black Canadians.
Protect public health
Regulate product quality and potency. Implement public education. Track and mitigate health harms.
Cannabis Act (Bill C-45), Government of Canada, 2018
What Actually Happened
The Numbers in Context
200 → 50
cannabis offences per 100,000 population, from 2010 to 2019. This single number represents the most unambiguous benefit of legalization — the end of mass cannabis criminalization in Canada. At the peak, cannabis arrests were consuming enormous police and court resources while disproportionately affecting marginalized communities.
For comparison, the United States still arrests approximately 350,000-500,000 people annually for cannabis offences, despite the growing patchwork of state legalization.
Hall et al. (2023)
7.5x
increase in pediatric hospitalizations for cannabis ingestion in four Canadian provinces after edibles became legal in October 2019. This is the most troubling unintended consequence. Edible cannabis products — gummies, chocolates, baked goods — are inherently attractive to children, and child-resistant packaging has proven insufficient.
The delay of edible legalization to October 2019 (one year after initial legalization) was supposed to give regulators time to prepare. The data suggests the safeguards were inadequate.
Hall et al. (2023)
The Black Market Question
One of the most important findings was that the black market is resilient but shrinking. Legal purchases rose from 23% to 68% of the market between 2018 and 2020, but that still meant roughly a third of cannabis purchases came from illegal sources.
Legal market is winning
Going from 23% to 68% legal market share in two years is rapid progress. Price declines, quality assurance, and convenience are steadily eroding the illegal market. Most new users enter through the legal market.
Statistics Canada data shows continued growth in legal sales revenue and declining illegal market estimates through 2023.
Regulations are hampering competition
Excessive taxation, strict product limits (e.g., 10mg THC cap per edible serving), plain packaging requirements, and slow licensing processes make it hard for the legal market to compete on price, convenience, and product variety.
In the early years, roughly 40% of sales remained illegal. Some provinces were slower to open retail stores. Many experienced cannabis users preferred the variety and potency available from illegal sources.
Complete displacement was never realistic
No legal market for any previously prohibited substance has ever completely eliminated illegal supply. Alcohol prohibition ended in 1933 and moonshine still exists. The goal should be significant displacement, not total elimination.
The 68% legal market share achieved by 2020 is comparable to or better than early years of alcohol legalization in many jurisdictions.
Hall et al. (2023); Statistics Canada
The Edibles Problem
The staggered legalization — flower and oils in October 2018, edibles in October 2019 — created a natural experiment that made one thing clear: edibles are the highest-risk product category from a public health standpoint.
- Dried Flower (Smoking/Vaping) moderate
Standard harm reduction advice applies: lower temperature vaporization preferred over combustion
The traditional product category. Rapid onset (minutes) means users can titrate their dose. Respiratory risks exist but are well-understood. Adult hospital visits increased modestly.
- Edibles high
Canada implemented 10mg THC caps per serving and child-resistant packaging, but pediatric incidents still surged
Delayed onset (30-120 minutes) leads to accidental overconsumption. Attractive to children. 7.5x increase in pediatric hospitalizations post-legalization. Responsible for disproportionate share of ER visits.
- Concentrates/Extracts moderate
Potency limits have been debated but not implemented in most provinces
High potency (60-90% THC) products became widely available. Linked to increased emergency department presentations for psychiatric distress and cannabinoid hyperemesis syndrome.
- Oils/Capsules low
Often preferred by medical cannabis patients for dosing precision
Precise dosing. Minimal appeal to children. No respiratory exposure. Slower onset than smoking but more predictable than edibles.
Hall et al. (2023)
What People Get Wrong
Myth vs. Reality
The Evidence
Evidence-based analysis
Implications for the United States and Beyond
Canada's experience is the best available data for countries considering legalization, because it happened nationally and was tracked systematically. For Americans following legalization policy debates, the lessons are specific:
-
Youth use won't explode. This was the single most common prediction of legalization opponents, and Canada's data clearly contradicts it. Age restrictions, marketing bans, and education appear to work.
-
Edible regulation matters enormously. The pediatric ingestion data is the strongest argument for strict edible packaging, dosing limits, and product appearance regulations. Child-appealing products (gummies, chocolates) are a genuine hazard.
-
The black market won't vanish without price competitiveness. Excessive taxation and regulatory burden keep illegal sources attractive. Jurisdictions that want to eliminate the black market need to compete on price.
-
Emergency department capacity needs expansion. A 22% increase in cannabis-related ER visits is manageable for a well-resourced health system, but it's a real cost that legalization budgets need to account for.
-
The criminal justice benefit is immediate and large. Of all the outcomes Hall tracked, the reduction in arrests is the most unambiguous. The human cost of cannabis criminalization — disproportionately borne by marginalized communities — ends the day legalization begins.
Key Takeaways
The implementation and public health impacts of cannabis legalization in Canada: a systematic review
Hall W, Stjepanovic D, Dawson D, Leung J (2023) · Addiction
Related Research
Key studies in this area
Racial disparities in marijuana arrests
Edwards, Bunting & Garcia (2020)
The criminal justice burden that legalization eliminates — Black Americans arrested at 3.73x the rate of white Americans despite equal use rates
Cannabis prohibition origins: Harry Anslinger
Musto (1999)
How cannabis became illegal in the first place — the racial and political roots of prohibition that legalization seeks to undo
Cannabis edible dosing and safety
Barrus et al. (2016)
The pharmacokinetic basis for why edibles are the highest-risk product category — delayed onset, variable absorption, and overconsumption risk
Adolescent cannabis and adult mental health
Gobbi et al. (2019)
The research that prompted Quebec to raise its legal age to 21 — demonstrating how legalization frameworks evolve in response to emerging evidence
THC potency has been rising for decades
ElSohly et al. (2016)
The potency context for legalization — regulated markets make potency transparent, while illegal markets had been driving potency up invisibly for decades
Lower-risk cannabis use guidelines
Fischer et al. (2017)
The harm reduction framework that informed Canada's public health approach to legalization
Did legalization cause more teenagers to use cannabis?
No. This was the most feared outcome, and it didn't happen. High school student cannabis use remained stable at approximately 17-18% after legalization. Multiple national surveys confirm this finding. Age restrictions, marketing bans, and school-based education appear to have been effective at maintaining the status quo.
Has the black market been eliminated?
Not yet, but it's significantly smaller. Legal purchases grew from 23% to 68% of all cannabis sales between 2018 and 2020. The illegal market persists because it can undercut legal prices (no taxes), offer greater product variety, and serve consumers who find the legal system inconvenient. Most experts believe the black market will continue shrinking as the legal market matures.
Are there more cannabis-related emergencies now?
Yes. Cannabis-attributable emergency department visits increased by about 22% after commercial retail sales began. The most alarming finding is the 7.5-fold increase in pediatric hospitalizations for cannabis ingestion after edibles became legal. Adult emergency visits for psychiatric distress and cannabinoid hyperemesis syndrome also increased.
Is driving while high a bigger problem now?
The evidence is mixed and frustrating. Self-reported survey data suggests impaired driving hasn't increased. But toxicological analysis of injured drivers in British Columbia showed THC prevalence ratios increased 1.33-2.29 times post-legalization. The discrepancy may reflect that THC can be detected in blood long after impairment has resolved, making toxicological data difficult to interpret.
What does this mean for US legalization?
Canada's experience suggests that careful, regulated legalization can achieve its criminal justice goals (reduced arrests) without causing the feared explosion in youth use. But it also shows that health consequences — particularly around edibles and emergency department visits — are real and require ongoing regulatory attention. The lesson isn't that legalization is either good or bad; it's that implementation details matter enormously.
What the researchers found
Cannabis legalization in Canada substantially reduced cannabis-related arrests and prices while increasing adult access to diverse products. Young adult use increased modestly but adolescent use remained stable.
Why it matters
As countries consider legalization, Canada serves as a real-world case study of what happens when cannabis becomes legal, showing both intended benefits and unintended health consequences.
The numbers in context
Research from 2006-2021 was reviewed. Cannabis prices decreased substantially. Adult use increased modestly since 2019. No marked changes in high school student use. Increased hospital visits for psychiatric distress, vomiting, and childhood edible ingestion.
How the study worked
Systematic review searching PubMed, Embase, Statistics Canada, government websites, and Google Scholar for studies published 2006-2021 on impacts of Canadian cannabis legalization.
Who was studied
Canadian population including adults, adolescents, and children, assessed through multiple national surveys and health records.
What this study cannot tell us
Narrative summary of a systematic search, which may be subject to synthesis bias. Short timeframe post-legalization may miss longer-term effects. Conflicting evidence on some outcomes like impaired driving.
How to read the evidence
Systematic review in Addiction (top addiction journal) providing comprehensive synthesis of post-legalization evidence. Limited by short follow-up period and reliance on heterogeneous data sources.
When this study was published
Published in 2023, reviewing research from 2006-2021. Covers the first 3 years after Canadian legalization (October 2018) and approximately 2 years after edibles legalization (October 2019).
The bigger picture
Canada's experience is the most comprehensive case study available for countries considering legalization. The data contradicts both catastrophist predictions (youth use explosion) and utopian promises (black market elimination). It demonstrates that legalization is not a single event but an ongoing regulatory challenge requiring continuous policy adjustment.
Questions still open
- Will the increases in cannabis-related hospital visits stabilize or continue rising? How will long-term health outcomes differ from pre-legalization baselines? Can edible regulations be designed to prevent pediatric incidents without driving consumers back to the black market? Will the US federal legalization debate use Canada's data constructively?
Common questions
Did legalization cause more teenagers to use cannabis?
Has the black market been eliminated?
Are there more cannabis-related emergencies now?
What does this mean for US legalization?
Read the original research
The implementation and public health impacts of cannabis legalization in Canada: a systematic review.
Addiction (Abingdon, England), 118(11), 2062-2072
Citation
Hall, Wayne; Stjepanović, Daniel; Dawson, Danielle; Leung, Janni. (2023). The implementation and public health impacts of cannabis legalization in Canada: a systematic review.. Addiction (Abingdon, England), 118(11), 2062-2072. https://doi.org/10.1111/add.16274